Abstract
In this study, the authors evaluated the combined impact of smoking and stress on catecholaminergic and cardiovascular reactivity in disease-free adult smokers. Smokers participated in 2 laboratory sessions, including a baseline and a mental-stressor phase (reaction time and mental math), once while smoking-deprived overnight and once while nondeprived. Nonsmoking controls also participated in an identical laboratory session, without the smoking manipulation. The authors obtained cardiovascular measures during each phase and measured catecholamine levels immediately after each phase. For nondeprived smokers, measures of norepinephrine, epinephrine, heart rate, and systolic blood pressure (SBP) were larger for the mental-stressor phase than for the baseline phase. The authors found no such increases for deprived smokers, and only SBP increased for controls from the baseline phase to the mental-stressor phase. The results suggest that ad lib smoking increases catecholamine and cardiovascular response to stress in smokers.
References
May 1, 1976·Psychological Medicine·M Carruthers
Jun 1, 1979·European Journal of Clinical Investigation·J Trap-JensenN J Christensen
Dec 1, 1977·Biochemical Medicine·M J Sole, M N Hussain
Sep 9, 1976·The New England Journal of Medicine·P E CryerS D Shah
Jul 1, 1992·Postgraduate Medical Journal·S MallyaC van Heyningen
Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·G GrassiG Mancia
Jun 1, 1992·Pharmacology, Biochemistry, and Behavior·K A PerkinsM Breus
Mar 1, 1991·Psychosomatic Medicine·Z TersmanP Eneroth
Nov 1, 1990·Psychophysiology·A L KasprowiczD S Krantz
May 1, 1990·Psychosomatic Medicine·J D LaneC M Kuhn
Jan 1, 1989·Psychopharmacology·D E Morse
Dec 1, 1989·Biological Psychology·P M CinciripiniH B Gjika
Jan 1, 1988·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·J M MacDougallM C Acevedo
Jan 1, 1985·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·T M DembroskiJ Krug-Fite
Jul 1, 1981·British Journal of Clinical Pharmacology·H HoubenA Van 'T Laar
Jan 1, 1983·Endocrine Reviews·S R Snider, O Kuchel
Sep 1, 1982·Journal of Behavioral Medicine·K O Fagerström
Aug 1, 1993·Circulation·O N NiedermaierD L Eckberg
Aug 1, 1996·Psychopharmacology·A TsudaC Kirschbaum
Dec 24, 1997·Circulation·T W KamarckJ T Salonen
Feb 25, 2000·Biological Psychology·J M McCafferyS B Manuck
Mar 14, 2003·Brain and Cognition·Christos PapadelisKostantinos Pappas
Jan 1, 1964·Journal of Chronic Diseases·W I WARDWELLC B BAHNSON
Jun 16, 2004·American Journal of Human Genetics·Y JiangR H Myers
Jan 6, 2005·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Martti T TuomistoVäinö Turjanmaa
May 4, 2011·Noise & Health·Wolfgang Babisch
Citations
Sep 23, 2011·Psychopharmacology·Rebecca L AshareSherry A McKee
Jan 15, 2011·Psychopharmacology·Margaret C WardleHarriet de Wit
Jan 22, 2008·Regulatory Toxicology and Pharmacology : RTP·John Bukowski
Apr 19, 2016·Psychopharmacology·Rebecca L AshareJames Loughead
Sep 24, 2015·PloS One·Yeon Wook KimKwang Ha Yoo
Dec 13, 2019·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Monique B NilssonJohn V Heymach
Jul 28, 2016·Oncology Reports·Ping HuWenhua Zhang